Evidence map›Paper›PMID 23990473›Full record

Trial reportThe Journal of biological chemistry2013

Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Cheng-Yeu Wu, Jan Martel, Wei-Yun Cheng, Chao-Chih He, David M Ojcius, John D Young

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Cheng-Yeu WuFrom the Laboratory of Nanomaterials,; the Center for Molecular and Clinical Immunology, and; the Research Center of Bacterial Pathogenesis, Chang Gung University, Gueishan, Taoyuan 333, Taiwan.
Jan MartelFrom the Laboratory of Nanomaterials,; the Center for Molecular and Clinical Immunology, and.
Wei-Yun ChengFrom the Laboratory of Nanomaterials,; the Center for Molecular and Clinical Immunology, and.
Chao-Chih HeFrom the Laboratory of Nanomaterials,; the Center for Molecular and Clinical Immunology, and.
David M Ojciusthe Center for Molecular and Clinical Immunology, and; the Molecular Cell Biology, Health Sciences Research Institute, University of California, Merced, California 95343.
John D YoungFrom the Laboratory of Nanomaterials,; the Center for Molecular and Clinical Immunology, and; the Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York 10021, and; the Biochemical Engineering Research Center, Ming Chi University of Technology, Taishan, Taipei 24301, Taiwan. Electronic address: dingeyoung@hotmail.com.
Center for Molecular Medicine and Immunology · USMing Chi University of Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies indicate that membrane vesicles (MVs) secreted by various cells are associated with human diseases, including arthritis, atherosclerosis, cancer, and chronic kidney disease. The possibility that MVs may induce the formation of mineralo-organic nanoparticles (NPs) and ectopic calcification has not been investigated so far. Here, we isolated MVs ranging in size between 20 and 400 nm from human serum and FBS using ultracentrifugation and sucrose gradient centrifugation. The MV preparations consisted of phospholipid-bound vesicles containing the serum proteins albumin, fetuin-A, and apolipoprotein A1; the mineralization-associated enzyme alkaline phosphatase; and the exosome proteins TNFR1 and CD63. Notably, we observed that MVs induced mineral precipitation following inoculation and incubation in cell culture medium. The mineral precipitates consisted of round, mineralo-organic NPs containing carbonate hydroxyapatite, similar to previous descriptions of the so-called nanobacteria. Annexin V-immunogold staining revealed that the calcium-binding lipid phosphatidylserine (PS) was exposed on the external surface of serum MVs. Treatment of MVs with an anti-PS antibody significantly decreased their mineral seeding activity, suggesting that PS may provide nucleating sites for calcium phosphate deposition on the vesicles. These results indicate that MVs may represent nucleating agents that induce the formation of mineral NPs in body fluids. Given that mineralo-organic NPs represent precursors of calcification in vivo, our results suggest that MVs may initiate ectopic calcification in the human body.

Indexed as

CalcinosisAlkaline PhosphataseAnimalsAnnexin A5Blood ProteinsCattleCell-Derived MicroparticlesDurapatiteFemaleHumansMalePhosphatidylserinesReceptors, Tumor Necrosis Factor, Type ITetraspanin 30Alkaline PhosphataseAnnexin A5Blood ProteinsCD63 protein, humanDurapatitePhosphatidylserinesReceptors, Tumor Necrosis Factor, Type ITetraspanin 30AtherosclerosisBiomineralizationCalcificationCalciumEctopic CalcificationMembrane VesiclesNanobacteriaPhosphatidylserine

Identifiers

PMID23990473
PMCPMC3798528
OpenAlexW1982601465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.